Jacques Irani

4.8k total citations
166 papers, 2.8k citations indexed

About

Jacques Irani is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Jacques Irani has authored 166 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Pulmonary and Respiratory Medicine, 58 papers in Surgery and 36 papers in Urology. Recurrent topics in Jacques Irani's work include Prostate Cancer Diagnosis and Treatment (55 papers), Prostate Cancer Treatment and Research (51 papers) and Bladder and Urothelial Cancer Treatments (47 papers). Jacques Irani is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (55 papers), Prostate Cancer Treatment and Research (51 papers) and Bladder and Urothelial Cancer Treatments (47 papers). Jacques Irani collaborates with scholars based in France, Germany and United Kingdom. Jacques Irani's co-authors include B. Doré, Jacques Aubert, Gaëlle Fromont, Fabien Saint, Jean‐Michel Goujon, Delphine Bon, P. Levillain, Didier Bon, O. Celhay and Alexandre de la Taille and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and The Journal of Urology.

In The Last Decade

Jacques Irani

151 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Irani France 30 1.5k 1.1k 611 490 428 166 2.8k
Rodney Davis United States 33 1.2k 0.8× 1.4k 1.2× 642 1.1× 417 0.9× 389 0.9× 91 2.8k
Bruce A. Lowe United States 25 1.7k 1.2× 1.5k 1.4× 592 1.0× 500 1.0× 569 1.3× 53 3.4k
Daniel B. Rukstalis United States 34 2.0k 1.4× 1.1k 1.0× 1.1k 1.8× 725 1.5× 320 0.7× 82 3.6k
B Debré France 31 1.3k 0.9× 900 0.8× 366 0.6× 787 1.6× 435 1.0× 138 2.5k
Ubirajara Ferreira Brazil 22 1.8k 1.2× 602 0.5× 301 0.5× 399 0.8× 345 0.8× 132 2.6k
Paul E. Andrews United States 30 1.7k 1.2× 974 0.9× 349 0.6× 662 1.4× 229 0.5× 94 2.6k
Marcus L. Quek United States 27 820 0.6× 1.8k 1.6× 732 1.2× 358 0.7× 503 1.2× 130 2.9k
Cesare Selli Italy 31 1.4k 1.0× 1.6k 1.5× 1.3k 2.1× 616 1.3× 372 0.9× 203 3.6k
Guilherme Godoy United States 29 1.5k 1.0× 1.4k 1.3× 422 0.7× 551 1.1× 285 0.7× 86 2.7k
Michaël Peyromaure France 25 1.3k 0.9× 709 0.6× 438 0.7× 344 0.7× 413 1.0× 126 2.3k

Countries citing papers authored by Jacques Irani

Since Specialization
Citations

This map shows the geographic impact of Jacques Irani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Irani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Irani more than expected).

Fields of papers citing papers by Jacques Irani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Irani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Irani. The network helps show where Jacques Irani may publish in the future.

Co-authorship network of co-authors of Jacques Irani

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Irani. A scholar is included among the top collaborators of Jacques Irani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Irani. Jacques Irani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pignot, G., Michaël Baboudjian, C. Lebâcle, et al.. (2023). Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure. World Journal of Urology. 41(11). 3195–3203. 10 indexed citations
2.
Ingels, Alexandre, Ingrid Leguerney, Paul-Henry Cournède, et al.. (2020). Ultrasound Molecular Imaging of Renal Cell Carcinoma: VEGFR targeted therapy monitored with VEGFR1 and FSHR targeted microbubbles. Scientific Reports. 10(1). 7308–7308. 17 indexed citations
3.
4.
Charles, T., et al.. (2017). Intérêt du test PCA3 avant une première série de biopsies prostatiques négatives : 5 ans de suivi. Progrès en Urologie. 27(5). 325–330. 6 indexed citations
5.
Bon, Delphine, Raphaël Thuillier, William Hébrard, et al.. (2014). Analysis of Perfusates During Hypothermic Machine Perfusion by NMR Spectroscopy. Transplantation. 97(8). 810–816. 28 indexed citations
6.
Godet, Julie, Nathalie Pedretti, François‐Xavier Bernard, et al.. (2013). Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: Association with tumor progression. Urologic Oncology Seminars and Original Investigations. 32(4). 426–432. 18 indexed citations
7.
Pfister, Christian, Morgan Rouprêt, Y. Neuzillet, et al.. (2013). Recommandations en onco-urologie 2013 du CCAFU : Tumeurs de la voie excrétrice urinaire supérieure. Progrès en Urologie. 23. S126–S132. 18 indexed citations
8.
Rébillard, Xavier, Pascale Grosclaude, Nathalie Léone, et al.. (2013). Projection de l’incidence et de la mortalité par cancer urologique en France en 2012. Progrès en Urologie. 23. S57–S65. 29 indexed citations
9.
10.
Colin, Pierre, A. Ouzzane, David Yates, et al.. (2012). Influence of Positive Surgical Margin Status After Radical Nephroureterectomy on Upper Urinary Tract Urothelial Carcinoma Survival. Annals of Surgical Oncology. 19(11). 3613–3620. 57 indexed citations
11.
12.
Pfister, Christian, Morgan Rouprêt, Hervé Wallerand, et al.. (2010). Recommandations en Onco-Urologie 2010 : Tumeurs urothéliales. Progrès en Urologie. 20. S255–S274. 42 indexed citations
13.
Normand, Guillaume, et al.. (2009). Percentage of Positive Biopsy Cores at the Onset of Hormone Therapy for Prostate Cancer: Prognostic Significance. Urologia Internationalis. 83(2). 160–165. 3 indexed citations
14.
15.
Teillac, Pierre, Aldo Bono, Jacques Irani, Manfred P. Wirth, & Alexandre R. Zlotta. (2005). The role of luteinizing hormone-releasing hormone therapy in locally advanced prostate cancer and biochemical failure: considerations for optimal use. Clinical Therapeutics. 27(3). 273–285. 4 indexed citations
16.
Desport, Éstelle, Frank Bridoux, Agnès Thierry, et al.. (2005). Papillary necrosis following segmental renal infarction: an unusual cause of early renal allograft dysfunction. Nephrology Dialysis Transplantation. 20(4). 830–833. 5 indexed citations
17.
Aubert, Jacques, Jacques Irani, & H. Baumert. (2000). Familial Ureteral Duplication and Ureterocele: Two Sisters and Their Father. European Urology. 37(6). 714–717. 3 indexed citations
18.
19.
Irani, Jacques, et al.. (1996). Patient acceptability of transurethral incision of the prostate under local anaesthesia. British Journal of Urology. 78(6). 904–906. 7 indexed citations
20.
Macrae, Duncan, et al.. (1964). A COMPARISON BETWEEN VAGINAL CYTOLOGY AND URINARY HORMONE EXCRETION DURING PREGNANCY. BJOG An International Journal of Obstetrics & Gynaecology. 71(4). 586–598. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rodney Davis Breakdown of academic impact, for papers by Bruce A. Lowe Breakdown of academic impact, for papers by Daniel B. Rukstalis Breakdown of academic impact, for papers by B Debré Breakdown of academic impact, for papers by Ubirajara Ferreira Breakdown of academic impact, for papers by Paul E. Andrews Breakdown of academic impact, for papers by Marcus L. Quek Breakdown of academic impact, for papers by Cesare Selli Breakdown of academic impact, for papers by Guilherme Godoy Breakdown of academic impact, for papers by Michaël Peyromaure
Rankless by CCL
2026